Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Vale Indonesia Tbk. (INCO) vs Tempo Scan Pacific Tbk. (TSPC)

Vale Indonesia Tbk.Trading
Tempo Scan Pacific Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Vale Indonesia Tbk. dan Tempo Scan Pacific Tbk.: Vale Indonesia Tbk. diperdagangkan di Rp4.960 (kapitalisasi pasar 51,96 T, volume 24 jam 10,73 jt), sedangkan Tempo Scan Pacific Tbk. diperdagangkan di Rp2.590 (kapitalisasi pasar 11,36 T, volume 24 jam 1,77 jt). Perbedaan utamanya: Vale Indonesia Tbk. jauh lebih besar — sekitar 4,6× kapitalisasi pasar Tempo Scan Pacific Tbk., dan Vale Indonesia Tbk. lebih aktif diperdagangkan (10,73 jt vs 1,77 jt). Mana yang lebih baik tergantung tujuan investasimu.

INCOTSPC
Kapitalisasi Pasar
51,96 T11,36 T
Volume
10,73 jt1,77 jt
Lot
107,28 rb17,71 rb
Perputaran
53,63 M4,61 M
Harga Rata-rata
4.999,122.603,9
Nilai Transaksi
53,63 M4,61 M
Harga Ekuilibrium Indikatif
4.9602.590
Volume Ekuilibrium Indikatif
4,56 rb300

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

INCO
Lihat detail
TSPC
Lihat detail

Tentang Vale Indonesia Tbk.

PT Vale Indonesia Tbk, formely PT International Nickel Indonesia, was established on July 25, 1968. PT. INCO produces nickel in matte, an intermediate product, from lateritic ores at its integrated mining and processing facilities near Soroako on the island of Sulawesi. The company is owned 58.7 % by Inco Limited of Canada, 20.1 % by Sumitomo Metal Mining Co., Ltd. of Japan.The Company is PMA

Selengkapnya di halaman INCO

Tentang Tempo Scan Pacific Tbk.

PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.

Selengkapnya di halaman TSPC